Abstract:Background and purpose: Chronic inflammation is pathogenic and contributes to human diseases, causing a significant threat to public health. The NLR family pyrin domain-containing protein 3 (NLRP3) is the best-characterized factor regulating inflammation. Therefore, targeting NLRP3 has the potential to treat inflammatory diseases and improve human health. Experimental approach: Lipopolysaccharide was used to induce inflammation in cell cultures. Lipopolysaccharide/d-galactosamine and dextran sulfate sodium salt were used to induce acute liver inflammation and ulcerative colitis respectively in C57BL/6J mice. Western blotting, immunofluorescence, immunoprecipitation, quantitative PCR and enzyme-linked immunosorbent assay (ELISA) were used to evaluate the activation of the inflammatory response in cell cultures and in mice. Key results: JNUTS013, a novel sorbicillinoid compound recently synthesized by us, significantly inhibited inflammation both in cell cultures and in mouse models. Mechanistically, JNUTS013 induced proteasome-dependent degradation of NLRP3. Hence, it suppressed the formation of the NLRP3 inflammasome and the production of downstream inflammatory cytokines and chemokines. The inhibitory effect of JNUTS013 on NLRP3 protein expression was confirmed in mice. Importantly, JNUTS013 failed to ameliorate bowel inflammation in Nlrp3-/- knockout mice, supporting NLRP3 as the biological target by which JNUTS013 inhibits inflammation. Further studies revealed critical chemical moieties of JNUTS013 required for inducing NLRP3 degradation. Conclusion and implications: This study identifies a novel compound JNUTS013 that inhibits inflammation through inducing NLRP3 protein degradation in vitro and in vivo, which not only supports the development of JNUTS013 as an anti-inflammation agent but also creates a new way for the treatment of inflammation by chemically inducing NLRP3 degradation.

Targeted Isolation of Sorbicilinoids from a Deep-Sea Derived Fungus with Anti-Neuroinflammatory Activities.

Anti-Inflammatory Sorbicilinoids from a Deep-Sea Derived Fungus Penicillium Rubens F54

Isolation and Characterization of Anti‐Inflammatory Sorbicillinoids from the Mangrove‐Derived Fungus Penicillium Sp. DM815

Synthesis of sorbicillinoid analogues with anti-inflammation activities

Anti-inflammatory Mono- and Dimeric Sorbicillinoids from the Marine-Derived Fungus Trichoderma Reesei 4670.

Targeted Discovery of Sorbicillinoid Pigments with Anti-Inflammatory Activity from the Sponge-Derived Fungus Stagonospora sp. SYSU-MS7888 Using the PMG Strategy.

Antiproliferative Sorbicillinoids from the Deep-Sea-Derived Penicillium Allii-Sativi

Anti-inflammatory monomeric sorbicillinoids from the marine-fish- derived fungus Trichoderma sp. G13

Sorbicillamines A-E, nitrogen-containing sorbicillinoids from the deep-sea-derived fungus Penicillium sp. F23-2.

Sorbicatechols A and B, Antiviral Sorbicillinoids from the Marine-Derived Fungus Penicillium Chrysogenum Pjx-17

Mono- and Dimeric Sorbicillinoid Inhibitors Targeting IL-6 and IL-1β from the Mangrove-Derived Fungus Trichoderma Reesei BGRg-3

New cytotoxic metabolites from a deep-sea-derived fungus, Phialocephala sp., strain FL30r.

Discovery Of Two New Sorbicillinoids By Overexpression Of The Global Regulator Laea In A Marine-Derived Fungus Penicillium Dipodomyis Yj-11

Novel sorbicillin analogues from the marine fungus Trichoderma sp. associated with the seastar Acanthaster planci.

Recent Advances in Sorbicillinoids from Fungi and Their Bioactivities (Covering 2016–2021)

Sorbicillasins A-B And Scirpyrone K From A Deep-Sea-Derived Fungus, Phialocephala Sp Fl30r

Sorbicillinoids From the Fungus Ustilaginoidea virens and Their Phytotoxic, Cytotoxic, and Antimicrobial Activities.

Sorbiterrin A, a novel sorbicillin derivative with cholinesterase inhibition activity from the marine-derived fungus Penicillium terrestre

Secondary metabolites from Penicillium sp. HS-11, a fungal endophyte of Huperzia serrata

New Sorbicillinoids from the Mangrove Endophytic Fungus Trichoderma Reesei SCNU-F0042.

A novel sorbicillinoid compound as a potent anti-inflammation agent through inducing NLRP3 protein degradation